Literature DB >> 4351756

Two distinct antigenic components in an Epstein-Barr virus-related early product induced by halogenated pyrimidines in non-producing human lymphoblastoid cells.

K Sugawara, T Osato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4351756     DOI： 10.1038/newbio243209a0

Source DB:  PubMed          Journal:  Nat New Biol        ISSN： 0090-0028


× No keyword cloud information.
  6 in total

1.  Characterization of a major protein with a molecular weight of 160,000 associated with the viral capsid of Epstein-Barr virus.

Authors:  B Vroman; J Luka; M Rodriguez; G R Pearson
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

2.  Epstein-Barr virus RNA. VI. Viral RNA in restringently and abortively infected Raji cells.

Authors:  W King; V Van Santen; E Kieff
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

3.  Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies.

Authors:  G R Pearson; B Vroman; B Chase; T Sculley; M Hummel; E Kieff
Journal:  J Virol       Date:  1983-07       Impact factor: 5.103

4.  Identification and mapping of Epstein-Barr virus early antigens and demonstration of a viral gene activator that functions in trans.

Authors:  K M Wong; A J Levine
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

5.  A redox-sensitive cysteine in Zta is required for Epstein-Barr virus lytic cycle DNA replication.

Authors:  Pu Wang; Latasha Day; Jayaraju Dheekollu; Paul M Lieberman
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

6.  Effects of 5-bromodeoxyuridine and 5-iododeoxyuridine on a latent herpes simplex virus infection.

Authors:  J Varani; J J Kelleher
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.